Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study
BackgroundBloodstream infections (BSIs) caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) have received much attention. However, few studies have identified risk factors for CRKP BSIs in comparison to CRKP non-bloodstream infections (non-BSIs). This study aimed to compare the epidemiology,...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1230721/full |
_version_ | 1797685478250512384 |
---|---|
author | Xiangyuan Sun Xiangyuan Sun Xiaocui Zou Boting Zhou Boting Zhou Tao Yin Tao Yin Ping Wang Ping Wang |
author_facet | Xiangyuan Sun Xiangyuan Sun Xiaocui Zou Boting Zhou Boting Zhou Tao Yin Tao Yin Ping Wang Ping Wang |
author_sort | Xiangyuan Sun |
collection | DOAJ |
description | BackgroundBloodstream infections (BSIs) caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) have received much attention. However, few studies have identified risk factors for CRKP BSIs in comparison to CRKP non-bloodstream infections (non-BSIs). This study aimed to compare the epidemiology, risk factors, and outcomes of CRKP BSIs and CRKP non-BSIs.MethodsWe conducted a retrospective study of patients infected with CRKP in the ICU from January 2012 to December 2020. Clinical characteristics and outcomes were compared between CRKP BSIs and CRKP non-BSIs. Predictors associated with 28-day all-cause mortality in CRKP-infected patients were also evaluated.Results326 patients infected with CRKP were enrolled, including 96 patients with CRKP BSIs and 230 with CRKP non-BSIs. The rates of CRKP BSIs in CRKP infections were generally raised from 2012 (12.50%) to 2020 (45.76%). Multivariate logistic analysis indicated that the use of carbapenems within the prior 90 days was an independent risk factor for CRKP BSIs (p = 0.019). Compared to CRKP non-BSIs, CRKP isolates in the CRKP BSI group were found to be non-susceptible to more tested carbapenems (p = 0.001). Moreover, the CRKP BSI group exhibited a higher mortality rate (p = 0.036). The non-susceptibility of CRKP isolates to more tested carbapenems (p = 0.025), a high SOFA score (p = 0.000), and the use of antifungal drugs within the prior 90 days (p = 0.018) were significant factors for 28-day all-cause mortality in CRKP-infected patients.ConclusionThe proportion of CRKP BSI increased progressively in CRKP-infected patients over 9 years. The use of carbapenems within the prior 90 days was an independent risk factor for the development of CRKP BSIs. The non-susceptibility of CRKP isolates to more tested carbapenems and a higher mortality rate were found in the CRKP BSI group. |
first_indexed | 2024-03-12T00:44:46Z |
format | Article |
id | doaj.art-0e1e320c98154746a607a50df72a66af |
institution | Directory Open Access Journal |
issn | 2296-858X |
language | English |
last_indexed | 2024-03-12T00:44:46Z |
publishDate | 2023-09-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Medicine |
spelling | doaj.art-0e1e320c98154746a607a50df72a66af2023-09-14T18:02:49ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2023-09-011010.3389/fmed.2023.12307211230721Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective studyXiangyuan Sun0Xiangyuan Sun1Xiaocui Zou2Boting Zhou3Boting Zhou4Tao Yin5Tao Yin6Ping Wang7Ping Wang8Department of Pharmacy, Xiangya Hospital, Central South University, Changsha Hunan, ChinaDepartment of Pharmacy, Lixian People’s Hospital, Lixian, Hunan, ChinaDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha Hunan, ChinaDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha Hunan, ChinaNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha Hunan, ChinaNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha Hunan, ChinaNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaBackgroundBloodstream infections (BSIs) caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) have received much attention. However, few studies have identified risk factors for CRKP BSIs in comparison to CRKP non-bloodstream infections (non-BSIs). This study aimed to compare the epidemiology, risk factors, and outcomes of CRKP BSIs and CRKP non-BSIs.MethodsWe conducted a retrospective study of patients infected with CRKP in the ICU from January 2012 to December 2020. Clinical characteristics and outcomes were compared between CRKP BSIs and CRKP non-BSIs. Predictors associated with 28-day all-cause mortality in CRKP-infected patients were also evaluated.Results326 patients infected with CRKP were enrolled, including 96 patients with CRKP BSIs and 230 with CRKP non-BSIs. The rates of CRKP BSIs in CRKP infections were generally raised from 2012 (12.50%) to 2020 (45.76%). Multivariate logistic analysis indicated that the use of carbapenems within the prior 90 days was an independent risk factor for CRKP BSIs (p = 0.019). Compared to CRKP non-BSIs, CRKP isolates in the CRKP BSI group were found to be non-susceptible to more tested carbapenems (p = 0.001). Moreover, the CRKP BSI group exhibited a higher mortality rate (p = 0.036). The non-susceptibility of CRKP isolates to more tested carbapenems (p = 0.025), a high SOFA score (p = 0.000), and the use of antifungal drugs within the prior 90 days (p = 0.018) were significant factors for 28-day all-cause mortality in CRKP-infected patients.ConclusionThe proportion of CRKP BSI increased progressively in CRKP-infected patients over 9 years. The use of carbapenems within the prior 90 days was an independent risk factor for the development of CRKP BSIs. The non-susceptibility of CRKP isolates to more tested carbapenems and a higher mortality rate were found in the CRKP BSI group.https://www.frontiersin.org/articles/10.3389/fmed.2023.1230721/fullCarbapenem resistanceKlebsiella pneumoniaebloodstream infectionnon-bloodstream infectionintensive care unit |
spellingShingle | Xiangyuan Sun Xiangyuan Sun Xiaocui Zou Boting Zhou Boting Zhou Tao Yin Tao Yin Ping Wang Ping Wang Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study Frontiers in Medicine Carbapenem resistance Klebsiella pneumoniae bloodstream infection non-bloodstream infection intensive care unit |
title | Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study |
title_full | Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study |
title_fullStr | Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study |
title_full_unstemmed | Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study |
title_short | Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study |
title_sort | comparison of bloodstream and non bloodstream infections caused by carbapenem resistant klebsiella pneumoniae in the intensive care unit a 9 year respective study |
topic | Carbapenem resistance Klebsiella pneumoniae bloodstream infection non-bloodstream infection intensive care unit |
url | https://www.frontiersin.org/articles/10.3389/fmed.2023.1230721/full |
work_keys_str_mv | AT xiangyuansun comparisonofbloodstreamandnonbloodstreaminfectionscausedbycarbapenemresistantklebsiellapneumoniaeintheintensivecareunita9yearrespectivestudy AT xiangyuansun comparisonofbloodstreamandnonbloodstreaminfectionscausedbycarbapenemresistantklebsiellapneumoniaeintheintensivecareunita9yearrespectivestudy AT xiaocuizou comparisonofbloodstreamandnonbloodstreaminfectionscausedbycarbapenemresistantklebsiellapneumoniaeintheintensivecareunita9yearrespectivestudy AT botingzhou comparisonofbloodstreamandnonbloodstreaminfectionscausedbycarbapenemresistantklebsiellapneumoniaeintheintensivecareunita9yearrespectivestudy AT botingzhou comparisonofbloodstreamandnonbloodstreaminfectionscausedbycarbapenemresistantklebsiellapneumoniaeintheintensivecareunita9yearrespectivestudy AT taoyin comparisonofbloodstreamandnonbloodstreaminfectionscausedbycarbapenemresistantklebsiellapneumoniaeintheintensivecareunita9yearrespectivestudy AT taoyin comparisonofbloodstreamandnonbloodstreaminfectionscausedbycarbapenemresistantklebsiellapneumoniaeintheintensivecareunita9yearrespectivestudy AT pingwang comparisonofbloodstreamandnonbloodstreaminfectionscausedbycarbapenemresistantklebsiellapneumoniaeintheintensivecareunita9yearrespectivestudy AT pingwang comparisonofbloodstreamandnonbloodstreaminfectionscausedbycarbapenemresistantklebsiellapneumoniaeintheintensivecareunita9yearrespectivestudy |